PA
ARKG icon

Parallel Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Parallel Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8K Hold
803
– – ﹤0.01% 2382
2026
Q1 		$21.2K Sell
803
-147
-15% -$4.3K ﹤0.01% 2460
2025
Q4 		$27.5K Buy
950
+147
+18% +$4.41K ﹤0.01% 2140
2025
Q3 		$22.3K Hold
803
– – ﹤0.01% 2187
2025
Q2 		$19.6K Sell
803
-417
-34% -$9.14K ﹤0.01% 2217
2025
Q1 		$25.3K Buy
1,220
+422
+53% +$10.6K ﹤0.01% 2015
2024
Q4 		$18.8K Hold
798
– – ﹤0.01% 2174
2024
Q3 		$20.4K Buy
798
+753
+1,673% +$19.2K ﹤0.01% 2088
2024
Q2 		$1.06K Sell
45
-105
-70% -$2.65K ﹤0.01% 2941
2024
Q1 		$4.31K Buy
150
+30
+25% +$902 ﹤0.01% 2573
2023
Q4 		$3.94K Hold
120
– – ﹤0.01% 2590
2023
Q3 		$3.34K Hold
120
– – ﹤0.01% 2644
2023
Q2 		$4.09K Hold
120
– – ﹤0.01% 2500
2023
Q1 		$3.61K Sell
120
-10
-8% -$310 ﹤0.01% 2539
2022
Q4 		$3.67K Hold
130
– – ﹤0.01% 2458
2022
Q3 		$4K Sell
130
-65
-33% -$2.39K ﹤0.01% 2362
2022
Q2 		$6K Sell
195
-166
-46% -$5.8K ﹤0.01% 2160
2022
Q1 		$17K Sell
361
-227
-39% -$10.8K ﹤0.01% 1795
2021
Q4 		$36K Buy
588
+14
+2% +$968 ﹤0.01% 1509
2021
Q3 		$43K Sell
574
-501
-47% -$42K ﹤0.01% 1336
2021
Q2 		$99K Buy
1,075
+178
+20% +$15.1K ﹤0.01% 955
2021
Q1 		$80K Buy
897
+681
+315% +$67.5K ﹤0.01% 977
2020
Q4 		$20K Buy
216
+43
+25% +$3.43K ﹤0.01% 1464
2020
Q3 		$11K Buy
+173
New +$10.1K ﹤0.01% 1684

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

Parallel Advisors's ARKG Position: Q2 2026 in Review

Parallel Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 803 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Parallel Advisors first reported a position in ARKG in Q3 2020 and has held it in 24 quarters since. The position peaked at $99K in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Parallel Advisors held 803 shares of ARK Genomic Revolution ETF worth $33.8K as of Q2 2026.
  • Parallel Advisors left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2382 holding.
  • Parallel Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 24 quarters since.
  • Parallel Advisors's ARK Genomic Revolution ETF position peaked at $99K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.